Fingerprint
Dive into the research topics of 'Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma
Mahmoud Elsawy*, Julio C. Chavez, Irit Avivi, Jean François Larouche, Luciano Wannesson, Kate Cwynarski, Keren Osman, Kelly Davison, Jakob D. Rudzki, Saurabh Dahiya, Kathleen Dorritie, Samantha Jaglowski, John Radford, Franck Morschhauser, David Cunningham, Alejandro Martin Garcia-Sancho, Dimitrios Tzachanis, Matthew L. Ulrickson, Reem Karmali, Natasha Kekre
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
5
Scopus
citations